Amanda Fitzpatrick

Clinical Senior Lecturer

King's College London

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom Professors in Medical Imaging Medical Imaging professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Amanda Fitzpatrick is a Clinical Senior Lecturer at King's College London, UK. Her research primarily focuses on immunotherapy for melanoma, brain and leptomeningeal metastasis, and advanced breast cancer treatments. Recent publications include investigations into the roles of tumor-associated macrophages and the impact of HER2 expression on prognosis in metastatic triple-negative breast cancer.

Articles (10)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Collaborators (4)

Patrick Derksen

PRINCIPAL INVESTIGATOR/PROFESSOR, PHD

Universitair Medisch Centrum Utrecht

NETHERLANDS

View details

isaac garcia-murillas

Institute of Cancer Research

UNITED KINGDOM

View details

Andrew Tutt

Institute of Cancer Research

UNITED KINGDOM

View details

Kieran Zucker

Clinical Lecturer

University of Leeds

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Amanda Fitzpatrick

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Chondroitin Sulfate Proteoglycan 4 (CSPG4) as an Emerging Target for Immunotherapy to Treat Melanoma

BMScope: A scoping review to chart the evolving clinical study landscape in brain and leptomeningeal metastasis

Tumor associated macrophages as key contributors and targets in current and future therapies for melanoma

Influence of HER2 expression on prognosis in metastatic triple-negative breast cancer—results from an international, multicenter analysis coordinated by the AGMT Study Group

Genomic profiling and pre-clinical modelling of breast cancer leptomeningeal metastasis reveals acquisition of a lobular-like phenotype

Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer.

Assessing CSF ctDNA to Improve Diagnostic Accuracy and Therapeutic Monitoring in Breast Cancer Leptomeningeal Metastasis

Correction: Loss of E-cadherin leads to Id2-dependent inhibition of cell cycle progression in metastatic lobular breast cancer (Oncogene, (2022), 41, 21, (2932-2944), 10.1038/s41388-022-02314-w)

Refining Therapy in Patients with HER2-Positive Breast Cancer with Central Nervous System Metastasis

Atlas of Lobular Breast Cancer Models: Challenges and Strategic Directions.

Collaborators (4)

Patrick Derksen

isaac garcia-murillas

Andrew Tutt

Kieran Zucker

Make your next move.